ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04722	Neurotrophin signaling pathway	6/16	160/7206	7.26997098037e-07
ko05100	Bacterial invasion of epithelial cells	5/16	99/7206	1.71333353626e-06
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/16	182/7206	3.38909390942e-05
ko04670	Leukocyte transendothelial migration	4/16	151/7206	0.000277108902492
ko04071	Sphingolipid signaling pathway	4/16	162/7206	0.000362713412107
ko05130	Pathogenic Escherichia coli infection	3/16	77/7206	0.000594414692616
ko05167	Kaposi's sarcoma-associated herpesvirus infection	4/16	191/7206	0.000677867856305
ko05210	Colorectal cancer	3/16	86/7206	0.000821520823069
ko04062	Chemokine signaling pathway	4/16	201/7206	0.000821534265503
ko05211	Renal cell carcinoma	3/16	96/7206	0.00113149473675
ko04510	Focal adhesion	4/16	240/7206	0.00159199911172
ko04666	Fc gamma R-mediated phagocytosis	3/16	122/7206	0.00225700578438
ko04810	Regulation of actin cytoskeleton	4/16	264/7206	0.00226157170733
ko04211	Longevity regulating pathway	3/16	123/7206	0.00231029293738
ko04660	T cell receptor signaling pathway	3/16	124/7206	0.00236436145097
ko05203	Viral carcinogenesis	4/16	277/7206	0.00269610191468
ko04015	Rap1 signaling pathway	4/16	278/7206	0.00273175828491
ko04014	Ras signaling pathway	4/16	279/7206	0.00276774119949
ko04380	Osteoclast differentiation	3/16	134/7206	0.0029489146779
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/16	135/7206	0.00301184390103
ko04931	Insulin resistance	3/16	137/7206	0.00314019271392
ko05160	Hepatitis C	3/16	153/7206	0.00428983274693
ko04215	Apoptosis - multiple species	2/16	47/7206	0.00471417508072
ko04611	Platelet activation	3/16	163/7206	0.00512341177645
ko05164	Influenza A	3/16	167/7206	0.00548251744567
ko04011	MAPK signaling pathway - yeast	2/16	53/7206	0.00596294464174
ko05418	Fluid shear stress and atherosclerosis	3/16	173/7206	0.006049271854
ko04217	Necroptosis	3/16	178/7206	0.00654770288648
ko04210	Apoptosis	3/16	180/7206	0.00675380869994
ko04150	mTOR signaling pathway	3/16	184/7206	0.00717767548154
ko05152	Tuberculosis	3/16	187/7206	0.00750585132733
ko05014	Amyotrophic lateral sclerosis (ALS)	2/16	74/7206	0.0113751392932
ko01524	Platinum drug resistance	2/16	76/7206	0.011971704471
ko04370	VEGF signaling pathway	2/16	77/7206	0.012275098865
ko04530	Tight junction	3/16	228/7206	0.0129047584157
ko04360	Axon guidance	3/16	233/7206	0.0136831369964
ko05131	Shigellosis	2/16	82/7206	0.0138426059161
ko05212	Pancreatic cancer	2/16	83/7206	0.0141661129676
ko04213	Longevity regulating pathway - multiple species	2/16	86/7206	0.0151563865584
ko05133	Pertussis	2/16	87/7206	0.0154930143044
ko04920	Adipocytokine signaling pathway	2/16	89/7206	0.0161759893688
ko04650	Natural killer cell mediated cytotoxicity	2/16	97/7206	0.0190354205704
ko05132	Salmonella infection	2/16	98/7206	0.0194069665418
ko04620	Toll-like receptor signaling pathway	2/16	100/7206	0.0201593178378
ko05200	Pathways in cancer	4/16	492/7206	0.0202144055517
ko05205	Proteoglycans in cancer	3/16	271/7206	0.0204825772286
ko04520	Adherens junction	2/16	103/7206	0.0213107879129
ko04024	cAMP signaling pathway	3/16	279/7206	0.0221159288732
ko01521	EGFR tyrosine kinase inhibitor resistance	2/16	106/7206	0.0224894634433
ko04972	Pancreatic secretion	2/16	111/7206	0.0245133914084
ko05166	HTLV-I infection	3/16	292/7206	0.0249215617452
ko04668	TNF signaling pathway	2/16	120/7206	0.028339047727
ko05162	Measles	2/16	120/7206	0.028339047727
ko04750	Inflammatory mediator regulation of TRP channels	2/16	122/7206	0.0292203051952
ko01522	Endocrine resistance	2/16	124/7206	0.0301126518577
ko04010	MAPK signaling pathway	3/16	321/7206	0.0318584540187
ko05142	Chagas disease (American trypanosomiasis)	2/16	130/7206	0.032855206697
ko04630	Jak-STAT signaling pathway	2/16	132/7206	0.0337908927642
ko04144	Endocytosis	3/16	342/7206	0.037466123449
ko04621	NOD-like receptor signaling pathway	2/16	157/7206	0.0463482810324
ko04152	AMPK signaling pathway	2/16	161/7206	0.0484982896343